Atlas Trials

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Clinical trial NCT00851721 · COMPLETED

Trial details

NCT number
NCT00851721
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Start date
2009-03-31
Primary completion
2012-10-17
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.